lusedra Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lusedra, and what generic alternatives are available?
Lusedra is a drug marketed by Eisai Inc and is included in one NDA.
The generic ingredient in LUSEDRA is fospropofol disodium. Additional details are available on the fospropofol disodium profile page.
Summary for lusedra
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 29 |
| Clinical Trials: | 8 |
| Patent Applications: | 54 |
| DailyMed Link: | lusedra at DailyMed |
Recent Clinical Trials for lusedra
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Grace Shih, MD | N/A |
| Mayo Clinic | Phase 4 |
| Eisai Inc. | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for lusedra
US Patents and Regulatory Information for lusedra
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eisai Inc | LUSEDRA | fospropofol disodium | SOLUTION;INTRAVENOUS | 022244-001 | Dec 12, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for lusedra
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Eisai Inc | LUSEDRA | fospropofol disodium | SOLUTION;INTRAVENOUS | 022244-001 | Dec 12, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
| Eisai Inc | LUSEDRA | fospropofol disodium | SOLUTION;INTRAVENOUS | 022244-001 | Dec 12, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for lusedra
See the table below for patents covering lusedra around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| New Zealand | 509795 | Water soluble prodrugs of hindered alcohols or phenols | ⤷ Try a Trial |
| Japan | 4554081 | ⤷ Try a Trial | |
| China | 1198834 | ⤷ Try a Trial | |
| Denmark | 1102776 | ⤷ Try a Trial | |
| Australia | 5339499 | ⤷ Try a Trial | |
| Russian Federation | 2235727 | РАСТВОРИМЫЕ В ВОДЕ ФОСФОНООКСИМЕТИЛОВЫЕ ЭФИРЫ ЗАТРУДНЕННЫХ СПИРТОВ ИЛИ ФЕНОЛОВ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ, СПОСОБ АНЕСТЕЗИИ И СПОСОБ ЛЕЧЕНИЯ ОПУХОЛЕВЫХ ЗАБОЛЕВАНИЙ (WATER-SOLUBLE PHOSPHONOOXYMETHYL ESTERS OF HINDERED ALCOHOLS AND PHENOLS, PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF, METHOD FOR ANESTHESIA AND METHOD FOR TREATMENT OF TUMOR DISEASES) | ⤷ Try a Trial |
| Norway | 20010659 | ⤷ Try a Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
